These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2909442)

  • 1. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.
    Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):647-55. PubMed ID: 2909442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients at risk for gastropathy associated with NSAID use.
    Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
    J Rheumatol Suppl; 1990 Feb; 20():12-9. PubMed ID: 2325051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
    Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
    Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing and understanding patient risk.
    Fries JF
    Scand J Rheumatol Suppl; 1992; 92():21-4. PubMed ID: 1574684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
    Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
    Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.
    Singh G
    Am J Med; 1998 Jul; 105(1B):31S-38S. PubMed ID: 9715832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcer complications and nonsteroidal anti-inflammatory drugs.
    Langman MJ
    Am J Med; 1988 Feb; 84(2A):15-9. PubMed ID: 3348238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models.
    Fries JF; Williams CA; Bloch DA; Michel BA
    Am J Med; 1991 Sep; 91(3):213-22. PubMed ID: 1892140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
    Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons.
    Smalley WE; Ray WA; Daugherty JR; Griffin MR
    Am J Epidemiol; 1995 Mar; 141(6):539-45. PubMed ID: 7900721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological aspects of NSAID gastropathy.
    Guslandi M
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():6-8. PubMed ID: 9032573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH; Salena BJ; Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use.
    Langman MJ
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):640-6. PubMed ID: 2642450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nonsteroidal antiinflammatory drugs with upper gastrointestinal disease: epidemiologic and economic considerations.
    Hochberg MC
    J Rheumatol Suppl; 1992 Nov; 36():63-7. PubMed ID: 1474537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects of treatment and prophylaxis of gastrointestinal side effects caused by non-steroidal-antiinflammatory drugs].
    Braun J; Sieper J
    Z Rheumatol; 1999 Aug; 58(4):173-84. PubMed ID: 10502016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum.
    Langman MJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S2-5. PubMed ID: 10379462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials.
    Boers M; Tangelder MJ; van Ingen H; Fort JG; Goldstein JL
    Ann Rheum Dis; 2007 Mar; 66(3):417-8. PubMed ID: 16887862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.